Abstract:Cisplatin-evoked profound gastrointestinal symptomatology is one of the most common side effects of chemotherapy drugs, causing further gastrointestinal cell and intestinal mucosal injury. Ginsenoside Rh4 (G-Rh4), an active component extracted from red ginseng, possesses beneficial anti-oxidative and anti-apoptosis effects. This study aimed to assess the effectiveness of pharmacological intervention with G-Rh4 mitigating intestinal toxicity evoked by cisplatin in a murine model and in IEC-6 cells in vitro. Following oral administration for 10 days, G-Rh4 (10[Formula: see text]mg/kg and 20[Formula: see text]mg/kg) significantly increased the indicators of diamine oxidase (DAO) affected by cisplatin (20[Formula: see text]mg/kg) in mice, and histopathological analysis further indicated that G-Rh4 could effectively improve intestinal tissue morphology, as well as the expression of peroxisome proliferator-activated receptor-gamma coactivator 1 [Formula: see text] (PGC-1[Formula: see text] pathway and autophagy-related proteins. Moreover, in vitro experiments demonstrated that G-Rh4 exerted a concentration-dependent increase in cell viability, while also inhibiting cytotoxicity and abnormal rise of reactive oxygen species (ROS). Notably, ROS also activate PGC-1[Formula: see text] protein and mediate the occurrence of mitochondrial autophagy and apoptosis pathways. The molecular docking approach was employed to dock G-Rh4 with PGC-1[Formula: see text] and AMPK, revealing a binding energy of [Formula: see text]7.3[Formula: see text]kcal/mol and [Formula: see text]8.1[Formula: see text]kcal/mol and indicating a tight interaction between the components and the target. G-Rh4 could reduce the expression of autophagy-related protein p62/p53, reduce the accumulation of autophagy products, and promote the flow of autophagy. In conclusion, G-Rh4 exerted protective effects against cisplatin-induced intestinal toxicity, at least partially through PGC-1[Formula: see text]-mediated autophagy and apoptosis.

Bismuth Reduces Cisplatin-Induced Nephrotoxicity Via Enhancing Glutathione Conjugation and Vesicular Transport.

Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress

A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein

Bismuth Porphyrin Antagonizes Cisplatin-Induced Nephrotoxicity Via Unexpected Metallothionein-Independent Mechanisms

Preventive Effect of Meglumine on Rat's Nephrotoxicity Induced by Cisplatin and Discussion on Its Mechanism

Protective Effect Of Metalloporphyrins Against Cisplatin-Induced Kidney Injury In Mice

Protective Effect of Bismuth Nitrate Pretreatment on Cisplatin Nephrotoxicity~1

Pyrocatechol Alleviates Cisplatin-Induced Acute Kidney Injury by Inhibiting ROS Production

Glutathione and Multidrug Resistance Protein Transporter Mediate a Self-Propelled Disposal of Bismuth in Human Cells.

Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds

A Novel 3-Phenylglutaric Acid Derivative (84-B10) Alleviates Cisplatin-Induced Acute Kidney Injury by Inhibiting Mitochondrial Oxidative Stress-Mediated Ferroptosis

Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis

Bisdemethoxycurcumin Attenuates Cisplatin-Induced Renal Injury Through Anti-Apoptosis, Anti-Oxidant and Anti-Inflammatory

Pretreatment of Huaiqihuang Extractum Protects Against Cisplatin-Induced Nephrotoxicity

Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis

Exposure and Nephrotoxicity Concern of Bismuth with the Occurrence of Autophagy

Exposure and nephrotoxicity concern of bismuth with the occurrence of autophagy.

Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity.

Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma.

Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.

Ginsenoside Rh4 Ameliorates Cisplatin-Induced Intestinal Toxicity Via PGC-1[Formula: See Text]-Mediated Mitochondrial Autophagy and Apoptosis Pathways.